1. Home
  2. ETS vs PHIO Comparison

ETS vs PHIO Comparison

Compare ETS & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETS
  • PHIO
  • Stock Information
  • Founded
  • ETS 2020
  • PHIO 2011
  • Country
  • ETS United States
  • PHIO United States
  • Employees
  • ETS N/A
  • PHIO N/A
  • Industry
  • ETS Trucking Freight/Courier Services
  • PHIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETS Industrials
  • PHIO Health Care
  • Exchange
  • ETS Nasdaq
  • PHIO Nasdaq
  • Market Cap
  • ETS 14.7M
  • PHIO 12.1M
  • IPO Year
  • ETS 2025
  • PHIO N/A
  • Fundamental
  • Price
  • ETS $0.72
  • PHIO $2.05
  • Analyst Decision
  • ETS
  • PHIO Strong Buy
  • Analyst Count
  • ETS 0
  • PHIO 3
  • Target Price
  • ETS N/A
  • PHIO $10.67
  • AVG Volume (30 Days)
  • ETS 127.8K
  • PHIO 67.1K
  • Earning Date
  • ETS 10-14-2025
  • PHIO 11-11-2025
  • Dividend Yield
  • ETS N/A
  • PHIO N/A
  • EPS Growth
  • ETS N/A
  • PHIO N/A
  • EPS
  • ETS N/A
  • PHIO N/A
  • Revenue
  • ETS $2,585,885.00
  • PHIO N/A
  • Revenue This Year
  • ETS N/A
  • PHIO N/A
  • Revenue Next Year
  • ETS N/A
  • PHIO N/A
  • P/E Ratio
  • ETS N/A
  • PHIO N/A
  • Revenue Growth
  • ETS 6.59
  • PHIO N/A
  • 52 Week Low
  • ETS $0.70
  • PHIO $0.97
  • 52 Week High
  • ETS $4.23
  • PHIO $9.79
  • Technical
  • Relative Strength Index (RSI)
  • ETS N/A
  • PHIO 39.83
  • Support Level
  • ETS N/A
  • PHIO $2.08
  • Resistance Level
  • ETS N/A
  • PHIO $2.17
  • Average True Range (ATR)
  • ETS 0.00
  • PHIO 0.09
  • MACD
  • ETS 0.00
  • PHIO -0.02
  • Stochastic Oscillator
  • ETS 0.00
  • PHIO 23.08

About ETS Elite Express Holding Inc. Class A Common Stock

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients' doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable, and innovative delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Share on Social Networks: